The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP, Kemper GM, Duggan MC, Stiff A, Noel TC, Markowitz J, Luedke EA, Yildiz VO, Yu L, Jaime-Ramirez AC, Karpa V, Zhang X, Carson WE 3rd.
Suarez-Kelly LP, et al. Among authors: zhang x.
Oncotarget. 2016 Dec 6;7(49):81172-81186. doi: 10.18632/oncotarget.12791.
Oncotarget. 2016.
PMID: 27783987
Free PMC article.